FIGURE 2.
FOXF2 expression is induced by AZA treatment in methylated breast cancer cells. A, the DNA methylation status of the FOXF2 proximal promoter was analyzed by bisulfite sequencing in AZA-treated cells. B, FOXF2 mRNA and protein levels were determined by qRT-PCR and immunoblotting in the indicated cells treated with varying concentrations of AZA. Data are presented as the mean ± S.D. of three independent experiments. *, p < 0.05.